Nano-engineered biomaterials: An Alternative Route for Drug Delivery in Lung Bioengineering

The lungs problems have been identified has as one the biggest factors of death and disability worldwide. Though transplantation of lungs is often the sole treatment option for numerous individuals, this procedure is severely constrained due to a scarcity of donor organs. The possibility for managing numerous ailments that have previously been incurable makes the technique of tissue engineering an exciting potential development, which deserves cautious consideration. As a result, the application of tissue technology and polymers for lungs bioengineering has drawn considerable interest from researchers. A range of scaffolding, including those made of polymers, lipids that are solid (SL), liposomes, as well as metals, have been successfully used in numerous experiments to bioengineer the lungs. Furthermore, advances in nanotechnology have created a remarkable chance to improve the qualities of tissue-engineered scaffolding even more. In order to further, simulate the extracellular matrix and surrounding that comprises real pulmonary tissue, nanotechnology efforts are primarily focused on providing innovative alternatives, notably for detecting and the therapy of lungs carcinoma by targeted drug delivery system. The word “Nanotechnology” has increased in popularity over the past several decades and is now nearly used interchangeably with novel and extremely exciting concepts. Nanotechnologies holds tremendous potential for addressing issues with current lung regeneration therapies, but it is still in the early stages and requires additional in vivo and extensive research in clinical trials.